INTRAVESICAL PROSTATIC PROTRUSION IN DIAGNOSING INFRAVESICAL OBSTRUCTION IN MEN WITH BENIGN PROSTATIC HYPERPLASIA


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Infravesical obstruction (IVO) is an important characteristic of the functional state of male lower urinary tract. It is believed that IVO confirmed by pressure-flow study findings warrants switching from a medical to surgical management of lower urinary tract symptoms (LUTS). Intravesical prostatic protrusion (IPP) is a new indicator for detecting IVO secondary to benign prostatic hyperplasia (BPH). This indicator has several advantages over other non-invasive methods for evaluating IVO. The initial findings on the relationship between IPP and IVO suggest the feasibility of its clinical use as a screening tool in men with obstructive voiding symptoms.

Full Text

Restricted Access

About the authors

G. G Krivoborodov

N.I. Pirogov RNRMU of Minzdrav of Russia; Russian Gerontology Research and Clinical Center

Email: dr.krivoborodov@yandex.ru
Dr.Med.Sci., Prof. at the Department of Urology and Andrology, Medical Faculty; Head of the Department of Urology Moscow, Russia

N. S Efremov

N.I. Pirogov RNRMU of Minzdrav of Russia; Russian Gerontology Research and Clinical Center

Email: nefr@yandex.ru
PhD, Associate Professor at the Department of Urology and Andrology, Medical Faculty; Urologist Moscow, Russia

A. D Bolotov

N.I. Pirogov RNRMU of Minzdrav of Russia; Russian Gerontology Research and Clinical Center

Email: adbolotov@gmail.com
PhD Student at the Department of Urology and Andrology, Medical Faculty; Urologist Moscow, Russia

References

  1. Chapple С., Abrams P. Lower Urinary Tract Symptoms (LUTS): An International Consultation on Male LUTS. Société Internationale d’Urologie (SIU), 2013.
  2. Kupelian V., Wei J.T., O’Leary M.P., Kusek J.W., Litman H.G., Link C.L., McKinlay J.B. BACH Survey Investigators. Prevalence of lower urinary tract symptoms and effect on quality of life in a racially and ethnically diverse random sample: the Boston Area Community Health (BACH) Survey. Arch. Intern. Med. 2006; 166(21):2381-7. doi: 10.1001/ archinte.166.21.2381.
  3. Agarwal A., Eryuzlu L.N., Cartwright R., Thorlund K., Tammela T.L., Guyatt G.H., Auvinen A.,Tikkinen K.A. What is the most bothersome lower urinary tract symptom? Individual- and population-level perspectives for both men and women. Eur. Urol. 2014;65(6):1211-1217. Doi: 10.1016/j. eururo.2014.01.019.
  4. Martin S.A., Haren M.T., Marshall V.R., Lange K., Wittert G.A. Members of the Froley Adelaide Male Aging Study. Prevalence and factors associated with uncomplicated storage and voiding lower urinary tract symptoms in community-dwelling Australian men. World. J. Urol. 2011;29(2):179-184. doi: 10.1007/s00345-010-0605-8.
  5. Abrams P., Cardozo L., Fall M., Griffiths D., Rosier P., Ulmsten U., Van Kerrebroeck P., Victor A., Wein A. Standardisation Sub-Committee of the International Continence Society. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Urology. 2003;61(1):37-49.
  6. Rohrmann S., Katzke V., Kaaks R. Prevalence and Progression of Lower Urinary Tract Symptoms in an Aging Population. Urology. 2016;95:158- 163. doi: 10.1016/j.urology.2016.06.021.
  7. Roehrborn C. Pathology ofbenign prostatic hyperplasia. Int. J. Impot. Res. 2008;20(3):11-18. doi: 10.1038/ijir.2008.55.
  8. McNeal J. Pathology of benign prostatic hyperplasia. Insight into etiology. Urol. Clin. North. Am. 1990;17(3):477-486.
  9. Kaprin A.D., Apolihin O.I., Sivkov A.V., Solnceva T.V., Komarova V.A. Analysis of uronefrologic morbidity and mortality in Russian Federation in the period of 2002-2014 according to official statistical data. Eksperimental’naja i klinicheskaja urologija. 2016;3:4-13
  10. Pushkar D.Ju., Rasner P.I., Harchilava R.R. Lower urinary tract symptoms and benign prostatic hyperplasia. Urologija. 2016;2:4-19
  11. Light H.G., Routledge J.A. Intra-abdominal pressure: Factor in hernia disease. Arch. Surg. 1965;90:115-117.
  12. Fox A., Tietze P.H., Ramakrishnan K. Anorectal conditions: hemorrhoids. FP essentials. 2014;419:11-19.
  13. Hong S.K., Lee S.T., Jeong S.J., Byun S.S., Hong Y.K., Park D.S., Hong J.Y., Son J.H., Kim C., Jang S.H., Lee S.E. Chronic kidney disease among men with lower urinary tract symptoms due to benign prostatic hyperplasia. BJU Int. 2010;105(10):1424-8. doi: 10.1111/j.1464-410X.2009.08975.x.
  14. Yamasaki T., Naganuma T., Iguchi T., Kuroki Y., Kuwabara N., Takemoto Y., Shoji T., Nakatani T. Association between chronic kidney disease and small residual urine volumes in patients with benign prostatic hyperplasia. Nephrology (Carlton). 2011 ; 16(3):335-339. Doi: 10.1111/j. 1440-1797.2010.01430.x.
  15. Glybochko P.V., Alyaev Yu.G., Gazimiyev M.A., Rudenko V.I., Askarov M.S., Bezhenar V.A., Akopyan G.N. Modern methods of diagnosis and treatment of urolithiasis with concomitant benign prostatic hyperplasia. Med. Vestnik Bashkortostana. 2011 ;6(2):43-46
  16. Reynard J.M., Yang Q., Donovan J.L., Peters T.J., Schafer W., de la Rosette J.J., Dabhoiwala N.F., Osawa D., Lim A.T., Abrams P. The ICS-’BPH’ Study: uroflowmetry, lower urinary tract symptoms and bladder outlet obstruction. Br. J. Urol. 1998;82(5):619-623.
  17. Zhao J., Zhao Z., Song J., Ji Z., Tian Y. The diagnostic accuracy and lower cutoff value of three methods for quantifying urethral resistance in men. Urol. Int. 2011;86(1):90-94. doi: 10.1159/000319968.
  18. Lim C.S., Abrams P. The Abrams-Griffiths nomogram. World. J. Urol. 1995;13(1):34-39.
  19. Gazimiyev M.A. Echo-urodynamic diagnosis of urination disorders. Abstract of dissertation for the degree of Candidate of Medical Sciences. 1999.
  20. Kuo H.C. Clinical prostate score for diagnosis of bladder outlet obstruction by prostate measurements and uroflowmetry. Urology. 1999;54(1):90-96.
  21. Raychaudhuri B., Cahill D. Pelvic fasciae in urology. Ann.R.Coll.Surg. Engl. 2008;90(8):633-7. doi: 10.1308/003588408X321611.
  22. Zheng J., Pan J., Qin Y., Huang J., Luo Y., Gao X., Zhou X. Role for intravesical prostatic protrusion in lower urinary tract symptom: a fluid structural interaction analysis study. BMC Urol. 2015;15:86. doi: 10.1186/s12894-015-0081-y.
  23. Zhao M., Barber T., Cistulli P.A., Sutherland K., Rosengarten G. Simulation of upper airway occlusion without and with mandibular advancement in obstructive sleep apnea using fluid-structure interaction. J. Biomech. 2013;46(15):2586-92. doi: 10.1016/j.jbiomech.2013.08.010.
  24. Faludi R., Szulik M., D’hooge J., Herijgers P., Rademakers F., Pedrizzetti G., Voigt J.U. Left ventricular flow patterns in healthy subjects and patients with prosthetic mitral valves: an in vivo study using echocardiographic particle image velocimetry. J. Thorac. Cardiovasc. Surg. 2010; 139(6) : 1501-10. doi: 10.1016/j.jtcvs.2009.07.060.
  25. Sakuyama G., Ishii T., Yamanishi T., Igarashi T. MP-09.01 Hydrodynamic Aspects of Intravesical Protrusion of the Prostate in Patients with Voiding Dysfunction. Urology. 2011;78(3):94. Doi: http://dx.doi.org/10.1016/j. urology.2011.07.203.
  26. Hosseini G., Williams J., Avital E., Munjiza A., Xu D., Green J. Computational simulation of urinary system. San Francisco, USA. Proc. World. Congress. Eng. Comput. Sci. 2012.
  27. Chia S.J., Heng C.T., Chan S.P., Foo K.T. Correlation of intravesical prostatic protrusion with bladder outlet obstruction. BJU Int. 2003;91(4):371-374.
  28. Hung C.T., Lin A.T., Chen K.K., Chang L.S. The subjective assessment and pressure-flow study of outcome of surgical treatment for patients with prostatism and high voiding pressure. Chin. Med. J. (Engl). 1995;56(3):186-191.
  29. Lee M.K., Lee S.H., Hur N., Kim S., Choi B. Correlation between intravesical pressure and prostatic obstruction grade using computational fluid dynamics in benign prostatic hyperplasia. Proc. Inst. Mech. Eng. H. 2011;225(9):920-928.
  30. Chepurov A.K. Diagnosis and treatment of isolated middle lobe of benign prostatic hyperplasia (BPH). Influence of antropogenic factors on cardiovascular and nerve system. 1997; 270-271
  31. Al-Shukhri S.Kh. Features of clinical manifestation and treatment of bladder outlet obstruction in patients with hyperplasia of middle lobe of prostate. Nefrologija. 2006; 10(2):96-100
  32. Kabardokov A. H. Diagnosis of «valve effect» of benign prostatic hyperplasia due to middle lobe and selection of the method of treatment. Urologija and Nefrologija. 1998;3:8-12
  33. Ohnuki T., Kurokawa K., Katoh N., Fukabori Y., Shimizu K., Nakai K., Yamanaka H. Transrectal longitudinal ultrasonography of the prostate by electronic linear scanning. Hinyokika Kiyo. 1987;33(9):1385-1388.
  34. Yuen J.S., Ngiap J.T., Cheng C.W., Foo K.T. Effects of bladder volume on transabdominal ultrasound measurements of intravesical prostatic protrusion and volume. Int. J. Urol. 2002;9(4):225-229.
  35. Tan Y.H., Foo K.T. Intravesical prostatic protrusion predicts the outcome of a trial without catheter following acute urine retention. J. Urol. 2003;170(6 Pt 1):2339-2341. doi: 10.1097/01.ju.0000095474.86981.00.
  36. Lee L.S., Sim H.G., Lim K.B., Wang D., Foo K.T. Intravesical prostatic protrusion predicts clinical progression of benign prostatic enlargement in patients receiving medical treatment. Int. J. Urol. 2010;17(1):69-74. doi: 10.1111/j.1442-2042.2009.02409.x.
  37. Nose H., Foo K.T., Lim K.B., Yokoyama T., Ozawa H., Kumon H. Accuracy of two noninvasive methods of diagnosing bladder outlet obstruction using ultrasonography: intravesical prostatic protrusion and velocity-flow video urodynamics. Urology.2005;65(3):493-497. doi: 10.1016/j.urology.2004.10.014.
  38. Foo K.T. Decision making in the management of benign prostatic enlargement and the role of transabdominal ultrasound. Int. J. Urol. 2010;17(12):974-979. doi: 10.1111/j.1442-2042.2010.02668.x.
  39. Reis L.O., Barreiro G.C., Baracat J., Prudente A., D’Ancona C.A. Intravesical protrusion of the prostate as a predictive method of bladder outlet obstruction. Int. Braz. J. Urol. 2008;34(5):627-633; discussion 634-637.
  40. Lieber M.M., Jacobson D.J., McGree M.E., St Sauver J.L., Girman C.J., Jacobsen S.J. Intravesical prostatic protrusion in men in Olmsted County, Minnesota. J. Urol. 2009; 182(6):2819-2824. Doi: 10.1016/j. juro.2009.08.086.
  41. Shin S.H., Kim J.W., Kim J.W., Oh M.M., Moon du G. Defining the Degree of Intravesical Prostatic protrusion in Association With Bladder Outlet Obstruction. Korean J. Urol. 2013;54(6):369-72. Doi: 10.4111/ kju.2013.54.6.369.
  42. YuH.F., He Y.H., Yu K.Y., Wang Q., Huang P.T., Yang Y., Wu D.Z., Chen Y.H. Transabdominal ultrasound measurement of intravesical prostatic protrusion helps diagnosis of benign prostatic obstruction. Zhonghua Nan Ke Xue. 2008;14(7):628-630.
  43. Aganovic D., Hasanbegovic M., Prcic A., Kulovac B., Hadziosmanovic O. Which is a better indicator of bladder outlet obstruction in patients with benign prostatic enlargement-intravesical protrusion of prostate or bladder wall thickness? Med. Arch. 2012;66(5):324-348.
  44. Wang D., Huang H., Law Y.M., Foo K.T. Relationships between Prostatic Volume and Intravesical Prostatic Protrusion on Transabdominal Ultrasound and Benign Prostatic Obstruction in Patients with Lower Urinary Tract Symptoms. Ann. Acad. Med. Singapore. 2015;44(2):60-65.
  45. Dicuio M., Pomara G., Vesely S., Morelli G., Menchini Fabris F., Ales V., Damber J.E., Dahlstrand C. The use of prostatic intravesical protrusion correlated with uroflowmetry: a new method to measure obstruction in patients with LUTS due to BOO without using P/F studies. Arch. Ital. Urol. Androl. 2005;77(1):50-53.
  46. Bantis A., Zissimopoulos A., Kalaytzis C., Giannakopoulos S., Sountoulides P., Agelonidou E., Voudalikakis C., Touloupidis S. Correlation of serum prostate specific antigen, the volume and the intravesical prostatic protrusion for diagnosing bladder outlet obstruction in patients with benign prostate hyperplasia. Hell. J. Nucl. Med. 2007;10(2):138-143.
  47. Silay M.S. Comment: Comparison of intravesical prostatic protrusion, prostate volume and serum prostatic-specific antigen in the evaluation of bladder outlet obstruction. Int. J. Urol. 2007;14(7):672; author reply 672. doi: 10.1111/j.1442-2042.2007.01753.x.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies